Interferon-beta signaling in retinal mononuclear phagocytes attenuates pathological neovascularization

EMBO Molecular Medicine

Volumn 8, Issue 6, 2016, Pages 670-678

  Lückoff, Anika ^a   Caramoy, Albert ^a   Scholz, Rebecca ^a   Prinz, Marco ^b   Kalinke, Ulrich ^c   Langmann, Thomas ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

^c INSTITUTE OF INFECTION IMMUNOLOGY   (Germany)

Author keywords

Age related macular degeneration; Choroidal neovascularization; Interferon beta signaling; Macrophages; Microglia

Indexed keywords

ALPHA INTERFERON RECEPTOR; BETA INTERFERON RECEPTOR; RECOMBINANT BETA INTERFERON; TAMOXIFEN; BETA INTERFERON;

AGE RELATED MACULAR DEGENERATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; EYE ENUCLEATION; FEMALE; GENE; GENE LOSS; GLIOSIS; HOMEOSTASIS; IFNAR1 GENE; IMMUNOHISTOCHEMISTRY; IMMUNOMODULATION; MACROPHAGE; MALE; MICROGLIA; MONONUCLEAR PHAGOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RETINA CELL; RETINA FLUORESCEIN ANGIOGRAPHY; SIGNAL TRANSDUCTION; SUBRETINAL NEOVASCULARIZATION; TREATMENT OUTCOME; TREATMENT RESPONSE; ANIMAL; DISEASE MODEL; DRUG EFFECTS; IMMUNOLOGY; KNOCKOUT MOUSE; MACROPHAGE ACTIVATION; MACULAR DEGENERATION; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PHAGOCYTE; RETINA;

ANIMALS; DISEASE MODELS, ANIMAL; INTERFERON-BETA; MACROPHAGE ACTIVATION; MACULAR DEGENERATION; MICE; MICE, KNOCKOUT; NEOVASCULARIZATION, PATHOLOGIC; PHAGOCYTES; RETINA; SIGNAL TRANSDUCTION;

EID: 84964703061     PISSN: 17574676     EISSN: 17574684     Source Type: Journal    
DOI: 10.15252/emmm.201505994     Document Type: Article

References (41)

1. Augood CA, Vingerling JR, de Jong PT, Chakravarthy U, Seland J, Soubrane G, Tomazzoli L, Topouzis F, Bentham G, Rahu M et al (2006) Prevalence of age-related maculopathy in older Europeans: the European Eye Study (EUREYE). Arch Ophthalmol 124: 529-535
2. Axtell RC, Steinman L (2008) Type 1 interferons cool the inflamed brain. Immunity 28: 600-602
3. Bruttger J, Karram K, Wortge S, Regen T, Marini F, Hoppmann N, Klein M, Blank T, Yona S, Wolf Y et al (2015) Genetic cell ablation reveals clusters of local self-renewing microglia in the Mammalian Central Nervous System. Immunity 43: 92-106
4. Chen M, Zhao J, Luo C, Pandi SP, Penalva RG, Fitzgerald DC, Xu H (2012) Para-inflammation-mediated retinal recruitment of bone marrow-derived myeloid cells following whole-body irradiation is CCL2 dependent. Glia 60: 833-842
5. Cirino AC, Mathura JR Jr, Jampol LM (2006) Resolution of activity (choroiditis and choroidal neovascularization) of chronic recurrent punctate inner choroidopathy after treatment with interferon B-1A. Retina 26: 1091-1092
6. Combadière C, Feumi C, Raoul W, Keller N, Rodéro M, Pézard A, Lavalette S, Houssier M, Jonet L, Picard E et al (2007) CX3CR1-dependent subretinal microglia cell accumulation is associated with cardinal features of age-related macular degeneration. J Clin Invest 117: 2920-2928
7. Damani MR, Zhao L, Fontainhas AM, Amaral J, Fariss RN, Wong WT (2011) Age-related alterations in the dynamic behavior of microglia. Aging Cell 10: 263-276
8. Dann A, Poeck H, Croxford AL, Gaupp S, Kierdorf K, Knust M, Pfeifer D, Maihoefer C, Endres S, Kalinke U et al (2011) Cytosolic RIG-I-like helicases act as negative regulators of sterile inflammation in the CNS. Nat Neurosci 15:98-106
9. Detje CN, Meyer T, Schmidt H, Kreuz D, Rose JK, Bechmann I, Prinz M, Kalinke U (2009) Local type I IFN receptor signaling protects against virus spread within the central nervous system. J Immunol 182: 2297-2304
10. Goldmann T, Wieghofer P, Muller PF, Wolf Y, Varol D, Yona S, Brendecke SM, Kierdorf K, Staszewski O, Datta M et al (2013) A new type of microglia gene targeting shows TAK1 to be pivotal in CNS autoimmune inflammation. Nat Neurosci 16: 1618-1626
11. Gupta N, Brown KE, Milam AH (2003) Activated microglia in human retinitis pigmentosa, late-onset retinal degeneration, and age-related macular degeneration. Exp Eye Res 76: 463-471
12. Inoue M, Shinohara ML (2013) The role of interferon-β in the treatment of multiple sclerosis and experimental autoimmune encephalomyelitis - in the perspective of inflammasomes. Immunology 139: 11-18
13. Jager RD, Mieler WF, Miller JW (2008) Age-related macular degeneration. N Engl J Med 358: 2606-2617
14. Jin S, Kawanokuchi J, Mizuno T, Wang J, Sonobe Y, Takeuchi H, Suzumura A (2007) Interferon-beta is neuroprotective against the toxicity induced by activated microglia. Brain Res 1179: 140-146
15. Kamphuis E, Junt T, Waibler Z, Forster R, Kalinke U (2006) Type I interferons directly regulate lymphocyte recirculation and cause transient blood lymphopenia. Blood 108: 3253-3261
16. Karlstetter M, Scholz R, Rutar M, Wong WT, Provis JM, Langmann T (2015) Retinal microglia: just bystander or target for therapy? Prog Retin Eye Res 45: 30-57
17. Kettenmann H, Hanisch UK, Noda M, Verkhratsky A (2011) Physiology of microglia. Physiol Rev 91: 461-553
18. Kierdorf K, Erny D, Goldmann T, Sander V, Schulz C, Perdiguero EG, Wieghofer P, Heinrich A, Riemke P, Holscher C et al (2013) Microglia emerge from erythromyeloid precursors via Pu.1- and Irf8-dependent pathways. Nat Neurosci 16: 273-280
19. Kimoto T, Takahashi K, Tobe T, Fujimoto K, Uyama M, Sone S (2002) Effects of local administration of interferon-beta on proliferation of retinal pigment epithelium in rabbit after laser photocoagulation. Jpn J Ophthalmol 46: 160-169
20. Lambert V, Lecomte J, Hansen S, Blacher S, Gonzalez ML, Struman I, Sounni NE, Rozet E, de Tullio P, Foidart JM et al (2013) Laser-induced choroidal neovascularization model to study age-related macular degeneration in mice. Nat Protoc 8: 2197-2211
21. Langmann T (2007) Microglia activation in retinal degeneration. J Leukoc Biol 81: 1345-1351
22. Levy O, Calippe B, Lavalette S, Hu SJ, Raoul W, Dominguez E, Housset M, Paques M, Sahel JA, Bemelmans AP et al (2015) Apolipoprotein E promotes subretinal mononuclear phagocyte survival and chronic inflammation in age-related macular degeneration. EMBO Mol Med 7: 211-226
23. McMenamin PG (1999) Dendritic cells and macrophages in the uveal tract of the normal mouse eye. Br J Ophthalmol 83: 598-604
24. Muller U, Steinhoff U, Reis LF, Hemmi S, Pavlovic J, Zinkernagel RM, Aguet M (1994) Functional role of type I and type II interferons in antiviral defense. Science 264: 1918-1921
25. Nimmerjahn A, Kirchhoff F, Helmchen F (2005) Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science 308: 1314-1318
26. Noel A, Jost M, Lambert V, Lecomte J, Rakic JM (2007) Anti-angiogenic therapy of exudative age-related macular degeneration: current progress and emerging concepts. Trends Mol Med 13: 345-352
27. Prinz M, Schmidt H, Mildner A, Knobeloch KP, Hanisch UK, Raasch J, Merkler D, Detje C, Gutcher I, Mages J et al (2008) Distinct and nonredundant in vivo functions of IFNAR on myeloid cells limit autoimmunity in the central nervous system. Immunity 28: 675-686
28. Rofagha S, Bhisitkul RB, Boyer DS, Sadda SR, Zhang K, SEVEN-UP Study Group (2013) Seven-year outcomes in ranibizumab-treated patients in ANCHOR, MARINA, and HORIZON: a multicenter cohort study (SEVEN-UP). Ophthalmology 120: 2292-2299
29. Sadler AJ, Williams BR (2008) Interferon-inducible antiviral effectors. Nat Rev Immunol 8: 559-568
30. Sene A, Chin-Yee D, Apte RS (2015) Seeing through VEGF: innate and adaptive immunity in pathological angiogenesis in the eye. Trends Mol Med 21: 43-51
31. Sierra A, Gottfried-Blackmore AC, McEwen BS, Bulloch K (2007) Microglia derived from aging mice exhibit an altered inflammatory profile. Glia 55: 412-424
32. Soriano P (1999) Generalized lacZ expression with the ROSA26 Cre reporter strain. Nat Genet 21: 70-71
33. Steinman L, Merrill JT, McInnes IB, Peakman M (2012) Optimization of current and future therapy for autoimmune diseases. Nat Med 18: 59-65
34. Sun M, Yang Y, Yang P, Lei B, Du L, Kijlstra A (2011) Regulatory effects of IFN-beta on the development of experimental autoimmune uveoretinitis in B10RIII mice. PLoS One 6: e19870
35. Teige I, Treschow A, Teige A, Mattsson R, Navikas V, Leanderson T, Holmdahl R, Issazadeh-Navikas S (2003) IFN-beta gene deletion leads to augmented and chronic demyelinating experimental autoimmune encephalomyelitis. J Immunol 170: 4776-4784
36. Tobe T, Takahashi K, Ohkuma H, Uyama M (1995) The effect of interferon-beta on experimental choroidal neovascularization. Nippon Ganka Gakkai Zasshi 99: 571-581
37. Touil T, Fitzgerald D, Zhang GX, Rostami A, Gran B (2006) Cutting Edge: TLR3 stimulation suppresses experimental autoimmune encephalomyelitis by inducing endogenous IFN-beta. J Immunol 177: 7505-7509
38. Wieghofer P, Knobeloch KP, Prinz M (2015) Genetic targeting of microglia. Glia 63: 1-22
39. Yasukawa T, Kimura H, Tabata Y, Kamizuru H, Miyamoto H, Honda Y, Ogura Y (2002) Targeting of interferon to choroidal neovascularization by use of dextran and metal coordination. Invest Ophthalmol Vis Sci 43: 842-848
40. Yona S, Kim KW, Wolf Y, Mildner A, Varol D, Breker M, Strauss-Ayali D, Viukov S, Guilliams M, Misharin A et al (2013) Fate mapping reveals origins and dynamics of monocytes and tissue macrophages under homeostasis. Immunity 38: 79-91
41. Zhao L, Zabel MK, Wang X, Ma W, Shah P, Fariss RN, Qian H, Parkhurst CN, Gan WB, Wong WT (2015) Microglial phagocytosis of living photoreceptors contributes to inherited retinal degeneration. EMBO Mol Med 7: 1179-1197